Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
China · Delayed Price · Currency is CNY 6.65
+0.09 (1.37%)
Feb 4, 2026, 3:04 PM CST
SHE:000153 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 113.82 | 160.83 | 159.29 | 154.43 | 122.98 | 103.72 |
Depreciation & Amortization | 127.43 | 127.43 | 126.32 | 121.7 | 115.31 | 70.85 |
Other Amortization | 16.5 | 16.5 | 14.44 | 13.02 | 10.94 | 16.2 |
Loss (Gain) From Sale of Assets | 1.61 | 1.61 | -4.38 | 0.25 | 0.51 | 0.33 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.28 | 0.01 | 8.57 | 2.56 |
Loss (Gain) From Sale of Investments | -3.94 | -3.94 | 1.58 | -14.82 | -9.73 | -17.53 |
Provision & Write-off of Bad Debts | 7.38 | 7.38 | 0.69 | 4.51 | 1.54 | -0.94 |
Other Operating Activities | 102.01 | 34.64 | 36.91 | 39.35 | 40.39 | 43.74 |
Change in Accounts Receivable | -165.39 | -165.39 | -238.77 | -89.26 | -114.07 | 44.78 |
Change in Inventory | -18.38 | -18.38 | 126.41 | -44.9 | -40.4 | -40.69 |
Change in Accounts Payable | -33.2 | -33.2 | 54.5 | 261.41 | 138.84 | 64.16 |
Operating Cash Flow | 146.59 | 126.24 | 254.75 | 439.99 | 264.62 | 292.75 |
Operating Cash Flow Growth | -22.80% | -50.45% | -42.10% | 66.27% | -9.61% | 342.14% |
Capital Expenditures | -205.35 | -144.02 | -152.12 | -81.76 | -159.84 | -190.74 |
Sale of Property, Plant & Equipment | 0.22 | 0.47 | 3.1 | 5.63 | 1.05 | 0.36 |
Cash Acquisitions | - | - | - | - | - | 4.3 |
Investment in Securities | -28.6 | -117.18 | - | -27 | 6.9 | 79.33 |
Other Investing Activities | 8.55 | 9.27 | 5.36 | 3.74 | 0.34 | 21.85 |
Investing Cash Flow | -225.17 | -251.45 | -143.66 | -99.39 | -151.56 | -84.91 |
Long-Term Debt Issued | - | 1,156 | 887.62 | 855.6 | 900.6 | 985.76 |
Total Debt Issued | 1,306 | 1,156 | 887.62 | 855.6 | 900.6 | 985.76 |
Long-Term Debt Repaid | - | -1,033 | -993.2 | -834.56 | -1,002 | -1,157 |
Total Debt Repaid | -1,133 | -1,033 | -993.2 | -834.56 | -1,002 | -1,157 |
Net Debt Issued (Repaid) | 172.88 | 123.08 | -105.58 | 21.04 | -100.99 | -171.42 |
Issuance of Common Stock | - | - | - | 82.48 | - | - |
Repurchase of Common Stock | -2.88 | -0.18 | -0.35 | - | - | - |
Common Dividends Paid | -72.71 | -72.17 | -64.17 | -57.48 | -26.28 | -38.4 |
Other Financing Activities | 6.79 | -0.1 | 4.9 | -308.31 | - | - |
Financing Cash Flow | 104.08 | 50.63 | -165.2 | -262.27 | -127.27 | -209.82 |
Foreign Exchange Rate Adjustments | 0.06 | 0.17 | 0.17 | 0.09 | -0.34 | -0.57 |
Net Cash Flow | 25.56 | -74.43 | -53.93 | 78.42 | -14.54 | -2.54 |
Free Cash Flow | -58.76 | -17.78 | 102.64 | 358.23 | 104.78 | 102.01 |
Free Cash Flow Growth | - | - | -71.35% | 241.90% | 2.71% | - |
Free Cash Flow Margin | -1.42% | -0.41% | 2.40% | 8.95% | 2.87% | 3.07% |
Free Cash Flow Per Share | -0.13 | -0.04 | 0.22 | 0.81 | 0.24 | 0.23 |
Cash Income Tax Paid | 189.35 | 206.74 | 282.07 | 180.28 | 181.46 | 206.08 |
Levered Free Cash Flow | 33.57 | -132.77 | -126.98 | 450.22 | -145.6 | -188.37 |
Unlevered Free Cash Flow | 54.4 | -113.79 | -105.8 | 470.76 | -121.06 | -163.7 |
Change in Working Capital | -218.23 | -218.23 | -80.37 | 121.54 | -25.9 | 73.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.